STRM 📈 Streamline Health Solutions - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US86323X1063
STRM: Health, Technology, Solutions, Automation, Reconciliation, Coding, Analysis
Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in North America. The company offers RevID, a cloud-based automated revenue reconciliation software as a service (Saas) solution that delivers automated daily charge reconciliation, which identifies discrepancies between a provider's clinical and billing departments and ensures that every medical service is tracked, accounted for, and accurately billed and reduce revenue leakage; and eValuator, a coding analysis platform that delivers the capability of fully automated analysis on billing codes entered by a healthcare provider's coding team. It also provides Data Comparison Engine, a cloud-based SaaS system synchronization module that operates and automates the reconciliation of these systems to identify discrepancies or errors occurring between systems; CDI that provides an integrated on-premise or cloud-based software suite that enhances the productivity of CDI and Coding staff and enables the seamless sharing of patient data; and Financial Management Solutions, which offers financial staff across the healthcare enterprise with actionable and real-time financial data and key performance indicators to improve revenue realization. In addition, the company provides auditing and coding, software, and professional services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia. Web URL: https://www.streamlinehealth.net
Additional Sources for STRM Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
STRM Stock Overview
Market Cap in USD | 12m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception | 1996-04-18 |
STRM Stock Ratings
Growth 5y | -77.0% |
Fundamental | -54.6% |
Dividend | - |
Rel. Strength Industry | -1574 |
Analysts | 5/5 |
Fair Price Momentum | 2.79 USD |
Fair Price DCF | - |
STRM Dividends
No Dividends PaidSTRM Growth Ratios
Growth Correlation 3m | 40.6% |
Growth Correlation 12m | -50.1% |
Growth Correlation 5y | -48.3% |
CAGR 5y | -29.30% |
CAGR/Mean DD 5y | -0.71 |
Sharpe Ratio 12m | 0.23 |
Alpha | -75.26 |
Beta | 1.20 |
Volatility | 132.51% |
Current Volume | 50.6k |
Average Volume 20d | 56.1k |
What is the price of STRM stocks?
As of December 22, 2024, the stock is trading at USD 3.39 with a total of 50,575 shares traded.
Over the past week, the price has changed by -7.89%, over one month by -7.35%, over three months by +6.22% and over the past year by -34.38%.
As of December 22, 2024, the stock is trading at USD 3.39 with a total of 50,575 shares traded.
Over the past week, the price has changed by -7.89%, over one month by -7.35%, over three months by +6.22% and over the past year by -34.38%.
Is Streamline Health Solutions a good stock to buy?
No, based on ValueRay Fundamental Analyses, Streamline Health Solutions (NASDAQ:STRM) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -54.56 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of STRM as of December 2024 is 2.79. This means that STRM is currently overvalued and has a potential downside of -17.7%.
No, based on ValueRay Fundamental Analyses, Streamline Health Solutions (NASDAQ:STRM) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -54.56 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of STRM as of December 2024 is 2.79. This means that STRM is currently overvalued and has a potential downside of -17.7%.
Is STRM a buy, sell or hold?
Streamline Health Solutions has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy STRM.
Streamline Health Solutions has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy STRM.
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for STRM stock price target?
According to ValueRays Forecast Model, STRM Streamline Health Solutions will be worth about 3.1 in December 2025. The stock is currently trading at 3.39. This means that the stock has a potential downside of -9.44%.
According to ValueRays Forecast Model, STRM Streamline Health Solutions will be worth about 3.1 in December 2025. The stock is currently trading at 3.39. This means that the stock has a potential downside of -9.44%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 22.5 | 563.7% |
Analysts Target Price | 1.3 | -63.1% |
ValueRay Target Price | 3.1 | -9.4% |